A carregar...

Weight Change During Chemotherapy as a Potential Prognostic Factor for Stage Iii Epithelial Ovarian Carcinoma: A Gynecologic Oncology Group Study

OBJECTIVE: Platinum/paclitaxel-based chemotherapy is a current treatment for advanced epithelial ovarian cancer. We sought to explore the association between weight change during treatment and survival, as well as the association between pre-chemotherapy body mass index (BMI) and survival. METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hess, L.M., Barakat, R., Tian, C., Ozols, R.F., Alberts, D.S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2517223/
https://ncbi.nlm.nih.gov/pubmed/17675142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2007.06.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!